Malaria Vaccines Market Report 2026
Download Free Sample Buy Now
Malaria Vaccines Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Malaria Vaccines Market Report 2026

Global Outlook – By Agent (Plasmodium Falciparum, Plasmodium Vivax), By Vaccine Type (Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines), By Route Of Administration (Intramuscular, Subcutaneous, Intradermal, Other Routes Of Administration), By Distribution Channel (Public, Private) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Malaria Vaccines Market Overview

• Malaria Vaccines market size has reached to $6.24 billion in 2025

• Expected to grow to $27.18 billion in 2030 at a compound annual growth rate (CAGR) of 34.3%

• Growth Driver: Malaria Vaccine Market Poised For Growth Amidst Rising Mosquito-Related Diseases

• Market Trend: Innovative Vaccine Technologies Driving Rapid Growth Amid Rising Global Efforts To Combat Malaria

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Malaria Vaccines Market?

Malaria vaccines are specific vaccines designed to prevent malaria, a potentially deadly mosquito-borne infectious disease caused by parasites from the Plasmodium genus. These vaccines aim to provide immunity against the plasmodium parasites that cause malaria.

The main types of agents involved in malaria vaccines are plasmodium falciparum, plasmodium vivax, and anopheles species. Plasmodium falciparum is a protozoan parasite responsible for the most severe and deadly form of malaria in humans. The various types of vaccines include pre-erythrocytic, erythrocytic, multi-antigen, and others, which can be administered through various routes, such as intramuscular, subcutaneous, intradermal, and others. These are sold through several distribution channels, including public and private.

Malaria Vaccines Market Global Report 2026 Market Report bar graph

What Is The Malaria Vaccines Market Size and Share 2026?

The malaria vaccines market size has grown exponentially in recent years. It will grow from $6.24 billion in 2025 to $8.36 billion in 2026 at a compound annual growth rate (CAGR) of 33.9%. The growth in the historic period can be attributed to high malaria burden in endemic regions, long-standing global malaria eradication initiatives, funding support from international health organizations, limitations of antimalarial drug resistance, early success of first-generation malaria vaccines.

What Is The Malaria Vaccines Market Growth Forecast?

The malaria vaccines market size is expected to see exponential growth in the next few years. It will grow to $27.18 billion in 2030 at a compound annual growth rate (CAGR) of 34.3%. The growth in the forecast period can be attributed to increasing government funding for infectious disease prevention, rising climate-driven expansion of malaria-prone regions, growing demand for long-lasting immunity vaccines, advancements in vaccine research and clinical trials, expansion of immunization coverage in low-income countries. Major trends in the forecast period include expansion of next-generation malaria vaccines, growing focus on pediatric immunization programs, increasing public–private partnerships in vaccine deployment, rising emphasis on multi-antigen and combination vaccines, strengthening of mass vaccination campaigns in endemic regions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Malaria Vaccines Market Segmentation

1) By Agent: Plasmodium Falciparum, Plasmodium Vivax

2) By Vaccine Type: Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines

3) By Route Of Administration: Intramuscular, Subcutaneous, Intradermal, Other Routes Of Administration

4) By Distribution Channel: Public, Private

Subsegments:

1) By Plasmodium Falciparum: RTS,S/AS01 Vaccine, Experimental Vaccines

2) By Plasmodium Vivax: Candidate Vaccines In Development, Combination Vaccines

What Is The Driver Of The Malaria Vaccines Market?

A rise in the incidence of mosquito-related diseases is expected to propel the growth of the malaria vaccine market going forward. Mosquito-related diseases are a broad category of illnesses spread by the bite of an infected mosquito. The malaria vaccine, particularly the RTS, S/AS01 (RTS, S) vaccine, is used to prevent and reduce the impact of mosquito-borne infectious diseases by training the immune system to recognize and attack the parasite. For instance, in December 2024, according to the UK Health Security Agency (UKHSA), a UK-based government departments, the annual malaria report for 2023 shows that there were 2,106 cases of imported malaria reported in the UK. This is 26% higher than the cases reported in 2022. Therefore, the rise in the incidence of mosquito-related diseases is driving the growth of the malaria vaccine industry.

Key Players In The Global Malaria Vaccines Market

Major companies operating in the malaria vaccines market are GlaxoSmithKline Plc, Bharat Biotech International Limited, Serum Institute of India Private Limited, Sanaria Inc, BioNTech SE, Moderna Inc, Pfizer Inc, Novavax Inc, Takeda Pharmaceutical Company Limited, Sanofi SA, Zydus Lifesciences Limited, Valneva SE, GeoVax Labs Inc, Inovio Pharmaceuticals Inc, Vaxart Inc, CanSino Biologics Inc, Sinovac Biotech Ltd, Clover Biopharmaceuticals Inc, Biological E Limited, Emergent BioSolutions Inc

Global Malaria Vaccines Market Trends and Insights

Major companies operating in the malaria vaccines market are focusing on developing innovative solutions such as next-generation recombinant vaccines to meet the rising demand driven by increasing malaria prevalence, government support, and expanding immunization programs. Next-generation recombinant vaccines use advanced genetic engineering techniques to target multiple stages of the malaria parasite's life cycle, providing improved immune responses and longer-lasting protection compared to traditional vaccines that often target a single stage and offer limited efficacy. For instance, in October 2025, Government of the Republic of Zambia, launched the malaria vaccine R21/Matrix-M as part of its Expanded Programme on Immunisation. Developed collaboratively by the University of Oxford and the Serum Institute of India, this vaccine leverages a recombinant protein platform combined with the Matrix-M adjuvant to enhance immune response, is administered in a four-dose schedule starting from 6 months of age, and is designed to complement existing anti-malaria measures. The vaccine offers higher efficacy rates and aims to protect children in high and moderate transmission districts across Zambia, contributing significantly to malaria elimination efforts.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Malaria Vaccines Market?

In June 2025, Bharat Biotech International Limited (BBIL), an India-based biotechnology company, partnered with GSK plc, to reduce the price of the world’s first malaria vaccine, RTS,S, for children in endemic countries to less than $5. With this partnership, Bharat Biotech and GSK aim to expand access to life-saving malaria vaccination through process improvements, expanded production capacity, cost-effective manufacturing, and minimal profit margins, ensuring rollout in 12 African countries by the end of 2025 through routine immunisation programs. GSK plc is a UK-based biopharmaceutical company focused on science-driven healthcare solutions.

Regional Outlook

North America was the largest region in the malaria vaccines market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Malaria Vaccines Market?

The malaria vaccines market consists of sales of circumsporozoite protein (CSP) antigens, multi-component adjuvants, and circumsporozoite protein. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Malaria Vaccines Market Report 2026?

The malaria vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the malaria vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Malaria Vaccines Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $8.36 billion
Revenue Forecast In 2035 $27.18 billion
Growth Rate CAGR of 33.9% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Agent, Vaccine Type, Route Of Administration, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled GlaxoSmithKline Plc, Bharat Biotech International Limited, Serum Institute of India Private Limited, Sanaria Inc, BioNTech SE, Moderna Inc, Pfizer Inc, Novavax Inc, Takeda Pharmaceutical Company Limited, Sanofi SA, Zydus Lifesciences Limited, Valneva SE, GeoVax Labs Inc, Inovio Pharmaceuticals Inc, Vaxart Inc, CanSino Biologics Inc, Sinovac Biotech Ltd, Clover Biopharmaceuticals Inc, Biological E Limited, Emergent BioSolutions Inc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Malaria Vaccines Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Malaria Vaccines Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Malaria Vaccines Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Malaria Vaccines Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Sustainability, Climate Tech & Circular Economy

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Expansion Of Next-Generation Malaria Vaccines

4.2.2 Growing Focus On Pediatric Immunization Programs

4.2.3 Increasing Public–Private Partnerships In Vaccine Deployment

4.2.4 Rising Emphasis On Multi-Antigen And Combination Vaccines

4.2.5 Strengthening Of Mass Vaccination Campaigns In Endemic Regions

5. Malaria Vaccines Market Analysis Of End Use Industries

5.1 Public Health Agencies

5.2 Hospitals

5.3 Vaccination Centers

5.4 Non-Governmental Organizations

5.5 Research Institutes

6. Malaria Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Malaria Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Malaria Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Malaria Vaccines Market Size, Comparisons And Growth Rate Analysis

7.3. Global Malaria Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Malaria Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Malaria Vaccines Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Malaria Vaccines Market Segmentation

9.1. Global Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Plasmodium Falciparum, Plasmodium Vivax

9.2. Global Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines

9.3. Global Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intramuscular, Subcutaneous, Intradermal, Other Routes Of Administration

9.4. Global Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Public, Private

9.5. Global Malaria Vaccines Market, Sub-Segmentation Of Plasmodium Falciparum, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

RTS,S/AS01 Vaccine, Experimental Vaccines

9.6. Global Malaria Vaccines Market, Sub-Segmentation Of Plasmodium Vivax, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Candidate Vaccines In Development, Combination Vaccines

10. Malaria Vaccines Market Regional And Country Analysis

10.1. Global Malaria Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Malaria Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Malaria Vaccines Market

11.1. Asia-Pacific Malaria Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Malaria Vaccines Market

12.1. China Malaria Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Malaria Vaccines Market

13.1. India Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Malaria Vaccines Market

14.1. Japan Malaria Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Malaria Vaccines Market

15.1. Australia Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Malaria Vaccines Market

16.1. Indonesia Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Malaria Vaccines Market

17.1. South Korea Malaria Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Malaria Vaccines Market

18.1. Taiwan Malaria Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Malaria Vaccines Market

19.1. South East Asia Malaria Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Malaria Vaccines Market

20.1. Western Europe Malaria Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Malaria Vaccines Market

21.1. UK Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Malaria Vaccines Market

22.1. Germany Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Malaria Vaccines Market

23.1. France Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Malaria Vaccines Market

24.1. Italy Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Malaria Vaccines Market

25.1. Spain Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Malaria Vaccines Market

26.1. Eastern Europe Malaria Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Malaria Vaccines Market

27.1. Russia Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Malaria Vaccines Market

28.1. North America Malaria Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Malaria Vaccines Market

29.1. USA Malaria Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Malaria Vaccines Market

30.1. Canada Malaria Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Malaria Vaccines Market

31.1. South America Malaria Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Malaria Vaccines Market

32.1. Brazil Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Malaria Vaccines Market

33.1. Middle East Malaria Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Malaria Vaccines Market

34.1. Africa Malaria Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Malaria Vaccines Market, Segmentation By Agent, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Malaria Vaccines Market Regulatory and Investment Landscape

36. Malaria Vaccines Market Competitive Landscape And Company Profiles

36.1. Malaria Vaccines Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Malaria Vaccines Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Malaria Vaccines Market Company Profiles

36.3.1. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bharat Biotech International Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Serum Institute of India Private Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanaria Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. BioNTech SE Overview, Products and Services, Strategy and Financial Analysis

37. Malaria Vaccines Market Other Major And Innovative Companies

Moderna Inc, Pfizer Inc, Novavax Inc, Takeda Pharmaceutical Company Limited, Sanofi SA, Zydus Lifesciences Limited, Valneva SE, GeoVax Labs Inc, Inovio Pharmaceuticals Inc, Vaxart Inc, CanSino Biologics Inc, Sinovac Biotech Ltd, Clover Biopharmaceuticals Inc, Biological E Limited, Emergent BioSolutions Inc

38. Global Malaria Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Malaria Vaccines Market

40. Malaria Vaccines Market High Potential Countries, Segments and Strategies

40.1 Malaria Vaccines Market In 2030 - Countries Offering Most New Opportunities

40.2 Malaria Vaccines Market In 2030 - Segments Offering Most New Opportunities

40.3 Malaria Vaccines Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Malaria Vaccines Market, Overview Of Key Products - Product Examples
  • Table 2: Global Malaria Vaccines Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Malaria Vaccines Market, Supply Chain Analysis
  • Table 4: Global Malaria Vaccines Market, Major Raw Material Providers
  • Table 5: Global Malaria Vaccines Market, Major Resource Providers
  • Table 6: Global Malaria Vaccines Market, Major Manufacturers (Suppliers)
  • Table 7: Global Malaria Vaccines Market, Major Distributors And Channel Partners
  • Table 8: Global Malaria Vaccines Market, Key Technologies & Future Trends
  • Table 9: Global Malaria Vaccines Market, Major Trends
  • Table 10: Global Malaria Vaccines Market, Major End Users
  • Table 11: Global Malaria Vaccines Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Malaria Vaccines Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Malaria Vaccines Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Malaria Vaccines Market - TAM, US$ Billion, 2025
  • Table 15: Global Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Malaria Vaccines Market, Sub-Segmentation Of Plasmodium Falciparum, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Malaria Vaccines Market, Sub-Segmentation Of Plasmodium Vivax, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Malaria Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Malaria Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Malaria Vaccines Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Malaria Vaccines Market - Company Scoring Matrix
  • Table 97: GlaxoSmithKline Plc Financial Performance
  • Table 98: Bharat Biotech International Limited Financial Performance
  • Table 99: Serum Institute of India Private Limited Financial Performance
  • Table 100: Sanaria Inc Financial Performance
  • Table 101: BioNTech SE Financial Performance
  • Table 102: Global Malaria Vaccines Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Malaria Vaccines Market, Competitive Dashboard
  • Table 104: Global Malaria Vaccines Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Malaria Vaccines Market Size Gain ($ Billion), Segmentation By Agent, 2025 – 2030
  • Table 106: Global, Malaria Vaccines Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030
  • Table 107: Global, Malaria Vaccines Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

    Figure 1: Global Malaria Vaccines Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Malaria Vaccines Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Malaria Vaccines Market, Supply Chain Analysis
  • Figure 4: Global Malaria Vaccines Market, Major Raw Material Providers
  • Figure 5: Global Malaria Vaccines Market, Major Resource Providers
  • Figure 6: Global Malaria Vaccines Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Malaria Vaccines Market, Major Distributors And Channel Partners
  • Figure 8: Global Malaria Vaccines Market, Key Technologies & Future Trends
  • Figure 9: Global Malaria Vaccines Market, Major Trends
  • Figure 10: Global Malaria Vaccines Market, Major End Users
  • Figure 11: Global Malaria Vaccines Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Malaria Vaccines Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Malaria Vaccines Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Malaria Vaccines Market - TAM, US$ Billion, 2025
  • Figure 15: Global Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Malaria Vaccines Market, Sub-Segmentation Of Plasmodium Falciparum, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Malaria Vaccines Market, Sub-Segmentation Of Plasmodium Vivax, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Malaria Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Malaria Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Malaria Vaccines Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Malaria Vaccines Market - Company Scoring Matrix
  • Figure 97: GlaxoSmithKline Plc Financial Performance
  • Figure 98: Bharat Biotech International Limited Financial Performance
  • Figure 99: Serum Institute of India Private Limited Financial Performance
  • Figure 100: Sanaria Inc Financial Performance
  • Figure 101: BioNTech SE Financial Performance
  • Figure 102: Global Malaria Vaccines Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Malaria Vaccines Market, Competitive Dashboard
  • Figure 104: Global Malaria Vaccines Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Malaria Vaccines Market Size Gain ($ Billion), Segmentation By Agent, 2025 – 2030
  • Figure 106: Global, Malaria Vaccines Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030
  • Figure 107: Global, Malaria Vaccines Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Read More About Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Read More About Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

UV Disinfection Equipment Market Report 2026 - Global Outlook – By Component (UV Lamp, Controller Unit, Quartz Sleeve, Reactor Chamber, Other Components ), By Power Rating (Low, Medium, High ), By Application (Water Trea...

Automatic Effluent Samplers Market Report 2026 - Global Outlook – By Product Type (Portable Samplers, Stationary Samplers), By Distribution Channel (Direct Sales, Distributors), By Application (Industrial Wastewater, Mun...

Pediatric Vaccine Market Report 2026 - Global Outlook – By Vaccine Type (Monovalent, Multivalent ), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease,...

Erdheim Chester Disease Market Report 2026 - Global Outlook – By Treatment (Chemotherapy, Immunotherapy, Radiation Therapy, Other Treatments), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations)...

Audience Intelligence Platform Market Report 2026 - Global Outlook – By Type of Platform (Content Intelligence Platforms, Social Media Intelligence Platforms), By Deployment Type (On-Premise, Cloud), By Application (Gove...

Herbal Medicine Market Report 2026 - Global Outlook – By Product (Capsules And Tablets, Powders, Extracts, Syrups, Other Products), By Category (Herbal Pharmaceuticals, Herbal Functional Foods, Herbal Dietary Supplements...

Frequently Asked Questions

The Malaria Vaccines market was valued at $6.24 billion in 2025, increased to $8.36 billion in 2026, and is projected to reach $27.18 billion by 2030.

The global Malaria Vaccines market is expected to grow at a CAGR of 34.3% from 2026 to 2035 to reach $27.18 billion by 2035.

Some Key Players in the Malaria Vaccines market Include, GlaxoSmithKline Plc, Bharat Biotech International Limited, Serum Institute of India Private Limited, Sanaria Inc, BioNTech SE, Moderna Inc, Pfizer Inc, Novavax Inc, Takeda Pharmaceutical Company

Major trend in this market includes: Innovative Vaccine Technologies Driving Rapid Growth Amid Rising Global Efforts To Combat Malaria. For further insights on this market. request a sample here

North America was the largest region in the malaria vaccines market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the malaria vaccines market report are Asia-Pacific, South

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us